Eckels KH - Search Results

1

Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate.

Anderson KB, Gibbons RV, Edelman R, Eckels KH, Putnak RJ, Innis BL, Sun W. Anderson KB, et al. Among authors: eckels kh. J Infect Dis. 2011 Aug 1;204(3):442-50. doi: 10.1093/infdis/jir279. J Infect Dis. 2011. PMID: 21742844

2

Hepatitis A in the US Army: epidemiology and vaccine development.

Hoke CH Jr, Binn LN, Egan JE, DeFraites RF, MacArthy PO, Innis BL, Eckels KH, Dubois D, D'Hondt E, Sjogren MH, et al. Hoke CH Jr, et al. Among authors: eckels kh. Vaccine. 1992;10 Suppl 1:S75-9. doi: 10.1016/0264-410x(92)90550-4. Vaccine. 1992. PMID: 1335665

3

Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation.

Innis BL, Eckels KH, Kraiselburd E, Dubois DR, Meadors GF, Gubler DJ, Burke DS, Bancroft WH. Innis BL, et al. Among authors: eckels kh. J Infect Dis. 1988 Oct;158(4):876-80. doi: 10.1093/infdis/158.4.876. J Infect Dis. 1988. PMID: 3171230 No abstract available.

4

Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers.

Bancroft WH, Scott RM, Eckels KH, Hoke CH Jr, Simms TE, Jesrani KD, Summers PL, Dubois DR, Tsoulos D, Russell PK. Bancroft WH, et al. Among authors: eckels kh. J Infect Dis. 1984 Jun;149(6):1005-10. doi: 10.1093/infdis/149.6.1005. J Infect Dis. 1984. PMID: 6376649 Clinical Trial.

5

Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status.

Scott RM, Eckels KH, Bancroft WH, Summers PL, McCown JM, Anderson JH, Russell PK. Scott RM, et al. Among authors: eckels kh. J Infect Dis. 1983 Dec;148(6):1055-60. doi: 10.1093/infdis/148.6.1055. J Infect Dis. 1983. PMID: 6655288 Clinical Trial.

6

Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines.

Mackowiak PA, Wasserman SS, Tacket CO, Vaughn DW, Eckels KH, Dubois DR, Hoke CH, Edelman R. Mackowiak PA, et al. Among authors: eckels kh. Clin Infect Dis. 1994 Nov;19(5):948-50. doi: 10.1093/clinids/19.5.948. Clin Infect Dis. 1994. PMID: 7893886

7

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.

Edelman R, Tacket CO, Wasserman SS, Vaughn DW, Eckels KH, Dubois DR, Summers PL, Hoke CH. Edelman R, et al. Among authors: eckels kh. J Infect Dis. 1994 Dec;170(6):1448-55. doi: 10.1093/infdis/170.6.1448. J Infect Dis. 1994. PMID: 7995984 Clinical Trial.

8

Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination.

Green S, Kurane I, Edelman R, Tacket CO, Eckels KH, Vaughn DW, Hoke CH Jr, Ennis FA. Green S, et al. Among authors: eckels kh. J Virol. 1993 Oct;67(10):5962-7. doi: 10.1128/JVI.67.10.5962-5967.1993. J Virol. 1993. PMID: 8371350 Free PMC article.

9

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys.

Putnak R, Barvir DA, Burrous JM, Dubois DR, D'Andrea VM, Hoke CH, Sadoff JC, Eckels KH. Putnak R, et al. Among authors: eckels kh. J Infect Dis. 1996 Dec;174(6):1176-84. doi: 10.1093/infdis/174.6.1176. J Infect Dis. 1996. PMID: 8940206

10

T cell activation in vivo by dengue virus infection.

Kurane I, Innis BL, Hoke CH Jr, Eckels KH, Meager A, Janus J, Ennis FA. Kurane I, et al. Among authors: eckels kh. J Clin Lab Immunol. 1995;46(1):35-40. J Clin Lab Immunol. 1995. PMID: 9363590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters